vTv Therapeutics Inc.
VTVT
$33.28
-$0.43-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 17.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 17.00K |
| Cost of Revenue | 3.91M | 7.02M | 4.10M | 2.83M | 2.23M |
| Gross Profit | -3.91M | -7.02M | -4.10M | -2.83M | -2.22M |
| SG&A Expenses | 3.98M | 3.68M | 3.62M | 3.67M | 2.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.89M | 10.70M | 7.72M | 6.50M | 4.91M |
| Operating Income | -7.89M | -10.70M | -7.72M | -6.50M | -4.89M |
| Income Before Tax | -7.14M | -10.35M | -7.38M | -6.22M | -4.44M |
| Income Tax Expenses | -- | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -7.14M | -10.35M | -7.38M | -6.22M | -4.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | 1.65M | 1.33M | 1.13M | 803.00K |
| Net Income | -7.14M | -8.70M | -6.05M | -5.09M | -3.63M |
| EBIT | -7.89M | -10.70M | -7.72M | -6.50M | -4.89M |
| EBITDA | -7.88M | -10.70M | -7.72M | -6.49M | -4.87M |
| EPS Basic | -0.57 | -1.08 | -0.92 | -0.77 | -0.55 |
| Normalized Basic EPS | -0.36 | -0.60 | -0.50 | -0.42 | -0.30 |
| EPS Diluted | -0.57 | -1.08 | -0.92 | -0.77 | -0.55 |
| Normalized Diluted EPS | -0.36 | -0.60 | -0.50 | -0.42 | -0.30 |
| Average Basic Shares Outstanding | 12.45M | 8.06M | 6.59M | 6.58M | 6.58M |
| Average Diluted Shares Outstanding | 12.45M | 8.06M | 6.59M | 6.58M | 6.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |